Clinical Trials Browser

Phase 2 × lestaurtinib × Myeloid × Clear all

NCT00586651 2015-10-08

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Phase 2 Completed

Polycythemia Vera, Thrombocythemia, Essential

NCT00494585 2012-06-25

CEP-701 for PH-negative Myelofibrosis

Phase 2 Completed

27 enrolled 5 charts

MyeloidOther hematologic neoplasm

Leukemia, Primary Myelofibrosis